Development of Improved Models for Phosphodiesterase-4 Inhibitors with a Multi-Conformational Structure-Based QSAR Method

Phosphodiesterase-4 (PDE-4) is an important drug target for several diseases, including COPD (chronic obstructive pulmonary disorder) and neurodegenerative diseases. In this paper, we describe the development of improved QSAR (quantitative structure-activity relationship) models using a novel multi-conformational structure-based pharmacophore key (MC-SBPPK) method. Similar to our previous work, this method calculates molecular descriptors based on the matching of a molecule's pharmacophore features with those of the target binding pocket. Therefore, these descriptors are PDE4-specific, and most relevant to the problem under study. Furthermore, this work expands our previous SBPPK QSAR method by explicitly including multiple conformations of the PDE-4 inhibitors in the regression analysis, and thus addresses the issue of molecular flexibility. The nonlinear regression problem resulted from including multiple conformations has been transformed into a linear equation and solved by an iterative partial least square (iPLS) procedure, according to the Lukacova-Balaz scheme. 35 PDE-4 inhibitors have been analyzed with this new method, and predictive models have been developed. Based on the prediction statistics for both the training set and the test set, these new models are more robust and predictive than those obtained by traditional ligand-based QSAR techniques as well as that obtained with the SBPPK method reported in our previous work. As a result, multiple predictive models have been added to the collection of QSAR models for PDE4 inhibitors. Collectively, these models will be useful for the discovery of new drug candidates targeting the PDE-4 enzyme.

[1]  Stephen Grossberg,et al.  ART 2-A: An adaptive resonance algorithm for rapid category learning and recognition , 1991, Neural Networks.

[2]  Asit K Chakraborti,et al.  3D-QSAR studies of indole derivatives as phosphodiesterase IV inhibitors. , 2003, European journal of medicinal chemistry.

[3]  Alexander Golbraikh,et al.  Combinatorial QSAR of Ambergris Fragrance Compounds , 2004, J. Chem. Inf. Model..

[4]  Changping Yao,et al.  Broad spectrum neuroprotection profile of phosphodiesterase inhibitors as related to modulation of cell-cycle elements and caspase-3 activation , 2007, Neuroscience Letters.

[5]  Asit K Chakraborti,et al.  3D-QSAR studies on thieno[3,2-d]pyrimidines as phosphodiesterase IV inhibitors. , 2003, Bioorganic & medicinal chemistry letters.

[6]  Asit K Chakraborti,et al.  Comparative molecular field analysis (CoMFA) of phthalazine derivatives as phosphodiesterase IV inhibitors. , 2003, Bioorganic & medicinal chemistry letters.

[7]  Weifan Zheng,et al.  A New Structure-Based QSAR Method Affords both Descriptive and Predictive Models for Phosphodiesterase-4 Inhibitors , 2008, Current chemical genomics.

[8]  Thierry Langer,et al.  LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters , 2005, J. Chem. Inf. Model..

[9]  Alexander Golbraikh,et al.  Rational selection of training and test sets for the development of validated QSAR models , 2003, J. Comput. Aided Mol. Des..

[10]  S Subramaniam,et al.  Analytical shape computation of macromolecules: I. molecular area and volume through alpha shape , 1998, Proteins.

[11]  H Edelsbrunner,et al.  Analytical shape computation of macromolecules: II. Inaccessible cavities in proteins , 1998, Proteins.

[12]  William M Brown,et al.  Treating COPD with PDE 4 inhibitors , 2007, International journal of chronic obstructive pulmonary disease.

[13]  Xin Chen,et al.  Recursive Partitioning Analysis of a Large Structure-Activity Data Set Using Three-Dimensional Descriptors1 , 1998, J. Chem. Inf. Comput. Sci..

[14]  A. Shindel.  Randomized, Double-Blind, Crossover Trial of Sildenafil in Men With Mild to Moderate Erectile Dysfunction: Efficacy at 8 and 12 Hours Postdose , 2009 .

[15]  Viera Lukacova,et al.  Multimode Ligand Binding in Receptor Site Modeling: Implementation in CoMFA , 2003, J. Chem. Inf. Comput. Sci..

[16]  M. Fitzgerald,et al.  Phosphodiesterase 4 inhibitors for the treatment of COPD. , 2002, Chest.

[17]  Shaomeng Wang,et al.  How Does Consensus Scoring Work for Virtual Library Screening? An Idealized Computer Experiment , 2001, J. Chem. Inf. Comput. Sci..

[18]  Steven J Siegel,et al.  PDE inhibitors in psychiatry--future options for dementia, depression and schizophrenia? , 2007, Drug discovery today.